---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-069538"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:32:20.151390+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Avra Medical Robotics to acquire CardioVentures in reverse merger; SSI-DE holders to get 95% of stock

## Summary
- SSI-DE stockholders to receive 95% of post-merger Avra common stock plus Series A Preferred shares with 51% voting power.
- Avra provided $1.44M interim financing to SSI-DE; up to $5M in convertible notes sold to three accredited investors.
- Conditions include 1-for-10 reverse stock split, name change to 'SS Innovations, Inc.', and authorized shares increase to 250M.
- Dr. Srivastava to assign SSI intellectual property to Avra; current Avra directors to resign except Barry Cohen.

## SEC filing metadata
- accession: 0001213900-22-069538
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/0001213900-22-069538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/ea168119-8k_avramedical.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-069538
- JSON: https://secwatch.observer/filing/0001213900-22-069538.json
- Plain text: https://secwatch.observer/filing/0001213900-22-069538.txt

## Key facts
- Material Agreements
  SS Innovations International, Inc. entered into Merger Agreement with CardioVentures, Inc. and Dr. Sudhir Srivastava (effective 2022-11-07).
  - Action: entry
  - Agreement: merger
  - Counterparty: CardioVentures, Inc. and Dr. Sudhir Srivastava
  - Effective: 2022-11-07
  source text: On November 7, 2022, AVRA entered into a definitive Merger Agreement (the “ Merger Agreement ”), by and among AVRA, AVRA-SSI Merger Corporation, a Delaware corporation and wholly-owned subsidiary of AVRA (“ Merger Sub ”), CardioVentures, Inc., a Delaware corporation (“ SSI - DE ”) Dr. Sudhir Srivastava (“ Dr. Srivastava ”), who, through his holding company, owns a controlling interest in SSI-DE.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390022069538/0001213900-22-069538-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.